| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/11/2006 | WO2006048837A1 Use of leptin for the treatment and/or prophylaxis of disease associated with a mucus secretion defect |
| 05/11/2006 | WO2006048633A2 Combination comprising zd6474 and an antiandrogen |
| 05/11/2006 | WO2006048555A1 Peptide exhibiting, in particular an anti-hiv activity, method for the preparation thereof and a pharmaceutical composition containing said peptide |
| 05/11/2006 | WO2006048473A1 β-LACTAMIC RGD CYCLOPEPTIDES CONTAINING GAMMA (Ϝ) TURNS |
| 05/11/2006 | WO2006048452A2 Peptides for use in treating of obesity |
| 05/11/2006 | WO2006048451A1 Peptides for use in the treatment of obesity |
| 05/11/2006 | WO2006048450A2 Peptides for use in the treating obesity |
| 05/11/2006 | WO2006048156A1 Cyclic nonapeptide amides |
| 05/11/2006 | WO2006047949A1 The use of human urinary kallidinogenase for the manufacture of a medicine for the treatment of acute coronary syndromes |
| 05/11/2006 | WO2006047948A1 The use of human urinary kallidinogenase for the manufacture of a medicine for the treatment of sepsis |
| 05/11/2006 | WO2006047900A2 Novel topical application agents against mimic and age-related wrinkles |
| 05/11/2006 | WO2006047878A1 Cancer therapeutics and methods for their use |
| 05/11/2006 | WO2006047820A1 Use of calgranulin a and b in the promotion and inhibition of mineralized tissue formation |
| 05/11/2006 | WO2006039400A9 Fsh and fsh receptor modulator compositions and methods for inhibiting osteoclastic bone resorption and bone loss in osteoporosis |
| 05/11/2006 | WO2006034560A3 Prevention and treatment of mycoplasma-associated diseases |
| 05/11/2006 | WO2006034134A3 Antibacterial peptide with activity against b. anthracis |
| 05/11/2006 | WO2006026739A3 Methods to enhance hemodynamic stability using oxygen carrying compositions |
| 05/11/2006 | WO2006018450A3 Pharmaceutically active insulin receptor-modulating molecules |
| 05/11/2006 | WO2006017578A3 Peptide sequence for modulation of delta protein kinase c |
| 05/11/2006 | WO2006014744A3 Compounds that inhibit hsp90 protein-protein interactions with iap proteins |
| 05/11/2006 | WO2006014737A3 Growth hormone releasing hormone enhances the immune response induced by vaccination |
| 05/11/2006 | WO2006012627A3 Actrii receptor polypeptides, methods and compositions |
| 05/11/2006 | WO2005117937A3 Alpha-1- acid glycoprotein for the treatment of diabetes |
| 05/11/2006 | WO2005117927A3 Tissue protective cytokines with an extended therapeutic window |
| 05/11/2006 | WO2005112887A3 Composition comprising intercalated functional-active organic compounds |
| 05/11/2006 | WO2005108422A3 Ammonium/ammonia transporter |
| 05/11/2006 | WO2005106471A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 4 (ccr4) |
| 05/11/2006 | WO2005094282A3 Combination therapy comprising cloretazinetm |
| 05/11/2006 | WO2005090389A3 Isosteric transformation |
| 05/11/2006 | WO2005072766A3 Peptides that bind to hsp90 proteins |
| 05/11/2006 | WO2005056764A3 Inhibitors of type 2 vascular endothelial growth factor receptors |
| 05/11/2006 | WO2005048951A3 A novel human g-protein coupled receptor, hgprbmy8, expressed highly in brain |
| 05/11/2006 | WO2005045055A3 The use of plp with peg-rmetase in vivo for enhanced efficacy |
| 05/11/2006 | WO2005044313A3 Conjugates of angiotensin ii and an imaging moiety |
| 05/11/2006 | WO2005033272A3 In vivo synthesis of connective tissues |
| 05/11/2006 | WO2005003177A3 Molecules for the targeting and the in situ assembly of therapeutic proteins and use thereof |
| 05/11/2006 | WO2004096151A3 Methods and devices for the sustained release of multiple drugs |
| 05/11/2006 | WO2004056323A3 Method of treating angiogenic tissue growth |
| 05/11/2006 | WO2002098351A8 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 05/11/2006 | WO2002094997A3 Transcriptional regulation of target genes |
| 05/11/2006 | WO2002055100A9 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 05/11/2006 | US20060101529 Lymphocyte surface receptor that binds CAML and methods of use thereof |
| 05/11/2006 | US20060100573 Sensor system including a port body |
| 05/11/2006 | US20060100419 Prekallikrein depleted plasma derived albumin fraction |
| 05/11/2006 | US20060100415 aminalkylphosphonate-substituted vancomycin; chromatography; DIVINYLBENZENE-STYRENE COPOLYMER |
| 05/11/2006 | US20060100264 3,3'-Diindolylmethane immune activating compositions |
| 05/11/2006 | US20060100249 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 05/11/2006 | US20060100186 Trandsdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome |
| 05/11/2006 | US20060100161 Mitotic kinesin inhibitors and methods of use thereof |
| 05/11/2006 | US20060100160 Amino acid derived prodrugs of propofol, compositions and uses thereof |
| 05/11/2006 | US20060100159 Preventing desensitization of receptors |
| 05/11/2006 | US20060100158 For therapy and prophylaxis of Alzheimer's disease, diffuse Lewy body type of Alzheimer's disease, Down's syndrome, MCI ("Mild Cognitive Impairment"), Heriditary Cerebral Hemorrhage with Amyloidosis of Dutch-Type, Cerebral Amyloid Angiopathy, Traumatic Brain Injury, Stroke, Dementia, Parkinson's Disease |
| 05/11/2006 | US20060100157 Novel use of peptide compounds for treating pain in painful diabetic neuropathy |
| 05/11/2006 | US20060100156 Cell nucleus-entering compositions |
| 05/11/2006 | US20060100155 Method for the therapeutic management of endometriosis |
| 05/11/2006 | US20060100154 Long-acting gonadotropin-releasing hormone analogs and methods of use thereof |
| 05/11/2006 | US20060100153 HSulf-1 nucleic acids, polypeptides and methods of using |
| 05/11/2006 | US20060100152 Methods and compositions in treating pain and painful disorders using 9949, 14230, 760, 62553, 12216, 17719, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 16314, 1613, 1675, 9569 or 13424 molecules |
| 05/11/2006 | US20060100151 Methods of treating osteoarthritis using IL-17 receptor proteins in combination with TNF-receptor proteins |
| 05/11/2006 | US20060100150 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 05/11/2006 | US20060100149 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 05/11/2006 | US20060100148 Glutathione-S-transferase tag, hexahistidine tag, maltose binding protein tag, haemagglutinin tag, and cellulose binding protein; for treating and preventing Flaviviridae virus (e.g., hepatitis C virus) infections |
| 05/11/2006 | US20060100147 Anticancer peptide |
| 05/11/2006 | US20060100146 AWAT-related methods and articles |
| 05/11/2006 | US20060100145 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 05/11/2006 | US20060100144 Conjugates of insulin-like growth factor binding protein-4 and poly (ethylene glycol) |
| 05/11/2006 | US20060100142 Use of uk114 in the treatment of leishmaniasis |
| 05/11/2006 | US20060100141 Administering peptidic or peptidomimetic compound having segment competent for importation of molecule into mast cells, and asecond segment for having an anti-allergic effect within mast cells for reducing late phase inflammatory responses induced by mitogen activated protein kinase activation |
| 05/11/2006 | US20060100140 Combination of a) n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]2-methylphenyl}-4- (3-pyridyl)-2-pyrimidine-amine and b) a histone deacetylase inhibitor for the treatment of leukemia |
| 05/11/2006 | US20060100139 Pharmaceutical used for treating HIV infection, the composition and uses thereof |
| 05/11/2006 | US20060100137 Monodispersed insulin polypeptide-oligomer conjugates; for administering by mouth an effective amount of an insulin polypeptide derivative within one hour of ingestion of a meal by the patient to provide an insulin drug concentration in portal vein blood of 10-1,000 U/ml within 60 minutes |
| 05/11/2006 | US20060100136 Synergistic effects of combined administration of mirtazapine and a stimulant compound |
| 05/11/2006 | US20060100135 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 05/11/2006 | US20060100134 fusion proteins; drug delivery |
| 05/11/2006 | US20060100133 High beta-conglycinin products and their use |
| 05/11/2006 | US20060100132 Method for diagnosing inflammatory bowel disease |
| 05/11/2006 | US20060100131 Modulation of stem cell differentiation by modulation of caspase-3 activity |
| 05/11/2006 | US20060100130 Catalysis of the cis/trans-isomerisation of secondary amide peptide compounds |
| 05/11/2006 | US20060099708 Methods for diagnosis and treatment of MDK1 signal transduction disorders |
| 05/11/2006 | US20060099687 14926 Receptor, a novel G-protein coupled receptor |
| 05/11/2006 | US20060099684 Polypeptide of given sequence; inhibiting endothelial cell proliferation; restenosis, cancer, eye disorders |
| 05/11/2006 | US20060099676 Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes |
| 05/11/2006 | US20060099672 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types for example |
| 05/11/2006 | US20060099671 Methods and compositions for generating angiostatin |
| 05/11/2006 | US20060099658 PCA3, PCA3 genes, and methods of use |
| 05/11/2006 | US20060099635 Anti-GL50 antibodies |
| 05/11/2006 | US20060099622 Of given amino acid sequence; bind to antibodies; detecting integrin; diagnosing and treating disorders |
| 05/11/2006 | US20060099616 2'-O-methyl-phosphorothioate oligoribonucleotide modification; peptide nucleic acids, locked nucleic acids, and/or morpholino phosphorodiamidate oligonucleotides; splicing to skip hybridization |
| 05/11/2006 | US20060099608 Methods of diagnosing cardiovascular disease |
| 05/11/2006 | US20060099586 Eef1a2 for use in the prognosis, diagnosis, and treatment of cancer |
| 05/11/2006 | US20060099580 Methyl-cpg binding domain protein 2 homologs |
| 05/11/2006 | US20060099571 Protease and peptidase-resistant proteins; Drug screening for control of cell division, apoptosis; for cancer treatment |
| 05/11/2006 | US20060099324 Composition comprising viscous fibers and viscosity-lowering proteins |
| 05/11/2006 | US20060099275 Cell permeable peptides; inhibit NF-kB activation; inhibit anti-apoptotic processes in cancer cells to promote tumor cell death |
| 05/11/2006 | US20060099271 Contacting microparticles og biodegradable, biocompatible polymer matrix comprising a peptide with halogenated solvent with nonaqueous washing system |
| 05/11/2006 | US20060099268 Photochemically crosslinked collagen scaffolds and methods for their preparation |
| 05/11/2006 | US20060099264 biodegradable; biocompatible; colloids |
| 05/11/2006 | US20060099253 Antibiotic product formulation |
| 05/11/2006 | US20060099244 Liposomal formulation for oral administration of glutathione (reduced) |
| 05/11/2006 | US20060099243 Oral administering; oral delivering active materials to gastrointestinal system; tablet with enteric coating |